phendimetrazine tartrate


A short-acting central amphetamine-type anorexiant.

Adverse effects
Cardiotoxicity—tachycardia, arrhythmias, hypertension, cardiovascular collapse; nervous system—tremor, restlessness, agitation, insomnia, increased motor activity, headache, convulsions, coma, hyperreflexia; rarely, CVA, cerebral vasculitis; high risk of dependency, abuse.
References in periodicals archive ?
Food and Drug Administration (FDA) for Phendimetrazine Tartrate Tablets USP, 35mg.
The Phendimetrazine Tartrate approval is from an Elite ANDA filed approximately six years ago.
Over the last several months the company has acquired two prescription drugs that have enjoyed longtime success: Melfiat (phendimetrazine tartrate), an appetite suppressant; and Colrex, a combination product designed to treat multiple cold symptoms.